Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

184 recalls · Class I, newest first

Class I · High risk

1% LIDOCAINE HCl Injection

Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0391-2015
Class I · High risk

Heparin Sodium

Presence of Particulate Matter: A particulate, confirmed as human hair, was found sealed between the tube and film at the round seal of the unused administrative port of the container.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-7620-03 D-0324-2015
Class I · High risk

CUBICIN (daptomycin for injection)

Presence of Particulate Matter: Foreign particulate matter (tiny black specs) were observed at the bottom of the vial following reconstitution.

Terminated Particulate / foreign matter Cubist Pharmaceuticals, Inc. NDC 67919-011-01 D-0229-2015
Class I · High risk

Dianeal Low Calcium

Presence of Particulate Matter: particulate matter was found during the manufacturing process.

Terminated Particulate / foreign matter Baxter Healthcare Corp. NDC 0941-0457-05 D-1610-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter: The product was discolored and contained visible particulates (iron oxide) in the solution and embedded in the glass vial.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-0020-2015
Class I · High risk

Marcaine (bupivacaine HCl)

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1560-29 D-0002-2015
Class I · High risk

Soliris (eculizumab)

Presence of Particulate Matter: Product failed the appearance for the presence of visible particles under labeled storage condition.

Terminated Particulate / foreign matter Alexion Pharmaceuticals, Inc. NDC 25682-001-01 D-1512-2014
Class I · High risk

Coumadin for Injection

Presence of Particulate Matter: particulate matter identified as metallic-like and non-metallic cellulose fiber particles found in retain vials

Terminated Particulate / foreign matter Bristol-Meyers Squibb NDC 0590-0324-96 D-1595-2014
Class I · High risk

Marcaine (bupivacaine HCl)

Presence of Particulate Matter: Confirmed customer complaint of discolored solution with visible metal particles embedded in the glass vial and visible in the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-1559-10 D-1358-2014
Class I · High risk

1% LIDOCAINE HCl Injection

Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4279-02 D-0382-2015
Class I · High risk

Propofol Injectable Emulsion

Presence of Particulate Matter: A glass defect was found on the interior neck of the vial during a retain sample inspection where the glass vial contained visible embedded metallic particulate and free floating metallic particulates were also found in solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-4699-30 D-1547-2014
Class I · High risk

Venlafaxine HCl Extended-Release Capsules

Presence of Foreign Tablets/Capsules: report of a foreign capsule with markings (TKN 250) and identified as a Tikosyn (dofetilide) capsule was found in a bottle of Effexor XR (venlafaxine HCl) 150 mg capsules that was packaged in the same packaging campaign as the recalled lot

Terminated Particulate / foreign matter Greenstone Llc NDC 59762-0182-2 D-1361-2014
Class I · High risk

Effexor XR

Presence of Foreign Tablets/Capsules: A Pharmacist reported that a bottle of Effexor XR 150 mg capsules contained a single peach colored capsule printed TKN250 which was identified as a Tikosyn (dofetilide) capsule.

Terminated Particulate / foreign matter Pfizer Us Pharmaceutical Group NDC 0008-0836-21 D-1328-2014
Class I · High risk

Acetylcysteine Solution

Presence of Particulate Matter: During a review of retain samples, the firm found a glass particulate in one lot of Acetylcysteine Solution

Terminated Particulate / foreign matter Ben Venue Laboratories Inc NDC 0054-3025-02 D-1326-2014
Class I · High risk

DOBUTamine Injection

Presence of Particulate Matter: Discolored solution due to a chip in the glass at the neck of the vial, also glass particulate was found within the solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2344-02 D-1540-2014
Class I · High risk

Lidocaine HCl Injection

Presence of Particulate Matter- Confimed customer complaint of particulates embedded in glass container and in contact with product solution.

Terminated Particulate / foreign matter Hospira Inc. NDC 0409-2066-05 D-1278-2014
Class I · High risk

Hyperlyte CR

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-1943-20 D-1275-2014
Class I · High risk

ProcalAmine

Presence of Particulate Matter: B. Braun Medical Inc. is recalling several injectable products due to visible particulate matter found in reserve sample units.

Terminated Particulate / foreign matter B. Braun Medical Inc NDC 0264-1915-07 D-1274-2014

Recalls by year